Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TMS for PTSD in Youth

NCT: NCT07401225 · RECRUITING

NCT IDNCT07401225
StatusRECRUITING
Start Date2026-05-09
Completion2027-08-31

Brief Summary

The purpose of this study is to test whether transcranial magnetic stimulation, or TMS, is an acceptable and helpful treatment for ongoing symptoms of posttraumatic stress syndrome disorder (PTSD) in 12-20 year olds. Ongoing PTSD refers to symptoms that continue after completing trauma-focused psychotherapy. About 1 in 4 patients need additional help to overcome PTSD after completing psychotherapy. Currently, scientists do not know the best way to help adolescents with persistent PTSD, and this study will test TMS as a possible treatment, and hopefully lead to future studies including more people.

Frequently Asked Questions

What is TMS for PTSD in Youth?

TMS for PTSD in Youth is a clinical trial registered under NCT07401225. Current status: RECRUITING.

What is the status of NCT07401225?

The current status of NCT07401225 (TMS for PTSD in Youth) is: RECRUITING.

When did TMS for PTSD in Youth start?

TMS for PTSD in Youth started on 2026-05-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.